Disease based biobank

Disease-oriented biobanks (which may also be referred to as clinical biobanks) are placed at the interface between clinical practice and research. They collect biological samples from patients, aiming at discovery and validation of genetic and non-genetic risk factors of diseases. They are usually established in hospitals and research institutes, and multi-centre collections can raise from clinical trials and genetic studies. Two domains of clinical biobanks can be distinguished: tissue banks and rare disease biobanks. They represent disease-oriented biobanks as they collect samples and data within the context of clinical care. Biological materials found in such biobanks are collected from patients and represent residual material of samples taken as part of an exploration or a clinical follow-up. Samples for clinical studies and diagnostic purposes have been collected throughout the history of medicine.

World Conference on Regenerative Medicine 2015 Leipzig, Germany, Biomarkers for Cancer Immunotherapy San Francisco, USA, Biomarkers & Diagnostics World Congress Philadelphia, USA, ESBB conference Johannesburg, South Africa, ART World Congress Symposium on Safe and Efficient IVF New York City, USA, Keystone Cardiac Development, Regeneration and Repair (Z2) Snowbird, Utah, USA, Phacilitate Cell & Gene Therapy World Washington D.C., USA, Keystone Stem Cells and Cancer Breckenbridge, CO, USA, Keystone Stem Cells and Regeneration in the Digestive Organs (X6) Keystone, Colorado, USA, World Conference on Regenerative Medicine 2015 Leipzig Germany.

 

Disease-oriented biobanks which are also called as clinical biobanks are plays a key role for both clinical practice and research. These biobank collect biological samples from patients, aiming at discovery and validation of genetic and non-genetic risk factors of diseases. They are usually established in hospitals and research institutes, and multi-center collections for clinical trials and genetic studies. 

The global biobanking market is witnessing an exponential growth owing to the increasing prevalence of chronic diseases. Furthermore, biobanks are also playing an important role in the development of new drugs which is further augmenting the market growth. Various facilities such as hospitals, research laboratories, academic centers and commercial facilities collect biological specimens and biomaterials from biobanks. However, lack of high quality samples could pose a challenge to the growth of this industry. Global biobank market is categorized on the basis of disease based biobank, population biobanks and private sector biobank.

  • Infectious Diseases BioBank
  • Biobanking in Atherosclerotic Disease
  • rare disease biobank
  • genetic disease biobank
  • Clinical biobanks

Related Conference of Disease based biobank

June 15-16, 2020

24th Global Congress on Biotechnology

London, UK
July 15-16, 2020

12th World Congress and Expo on Stem Cell Research

Prague, Czech Republic
July 15-16, 2020

25th World Biotechnology Congress

London, UK
September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 21-22, 2020

International Conference on Genetic Disorders and Gene Therapy

Auckland, Newzealand
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-20, 2020

24th European Biotechnology Congress (EBC_2020)

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Disease based biobank Conference Speakers

Recommended Sessions

Related Journals

Are you interested in